SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-20-204865
Filing Date
2020-07-31
Accepted
2020-07-30 21:53:01
Documents
2
Group Members
HENRY A. PLAIN, JR.JASON W. LETTMANNJEAN M. GEORGELIGHTSTONE VENTURES (A), L.P.LIGHTSTONE VENTURES II (A), L.P.LIGHTSTONE VENTURES II, L.P.LIGHTSTONE VENTURES, L.P.LSV ASSOCIATES II, LLCMICHAEL A. CARUSI

Document Format Files

Seq Description Document Type Size
1 SC 13D d91132dsc13d.htm SC 13D 233889
2 EX-99.A d91132dex99a.htm EX-99.A 8468
  Complete submission text file 0001193125-20-204865.txt   244174
Mailing Address 500 BOYLSTON STREET, SUITE 1380 BOSTON MA 02116
Business Address 500 BOYLSTON STREET, SUITE 1380 BOSTON MA 02116 (617) 850-9700
LSV Associates, LLC (Filed by) CIK: 0001643828 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Subject) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91585 | Film No.: 201063491
SIC: 2834 Pharmaceutical Preparations